Roger Li

H Lee Moffitt Cancer Center and Research Institute

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (24)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (13)

youngchul kim

Moffitt Cancer Center

UNITED STATES

View details

Weranja Ranasinghe

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Neema Navai

UNITED STATES

View details

Jacob Taylor

NYU Langone Health

UNITED STATES

View details

Colin Dinney

Professor and Chairman

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Wei Shen Tan

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Ahmet Murat Aydin

Assistant Professor

University of Arkansas for Medical Sciences

UNITED STATES

View details

Justin Matulay

Assistant Professor

UNITED STATES

View details

Andrea Mari

Assistant Professor

Institute of Experimental Medicine

ITALY

View details

Gopal Narang

University of North Carolina Hospitals

UNITED STATES

View details

Paulo Rodriguez

Senior Member-Professor

H Lee Moffitt Cancer Center and Research Institute

UNITED STATES

View details

Gustavo Borjas

Case Western Reserve University

UNITED STATES

View details

Surena F. Matin

University of Texas at Austin

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Roger Li

Research Interests

Explore related searches

Contact this professor

Articles (24)

Metastasis development in non-muscle-invasive bladder cancer

Personalized neoantigen vaccines in urologic malignancies

A luminal non‐coding RNA‐based genomic classifier confirms favourable outcomes in patients with clinically organ‐confined bladder cancer treated with radical cystectomy

Letter: Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin–Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial

Author Correction: Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial

Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial

Publisher Correction: Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial

The optimal number of induction chemotherapy cycles in clinically lymph node‐positive bladder cancer

Comparative Effectiveness of Neoadjuvant Pembrolizumab Versus Cisplatin-based Chemotherapy or Upfront Radical Cystectomy in Patients with Muscle-invasive Urothelial Bladder Cancer

The Elusive Horizon: Biomarkers in Urothelial Carcinoma

Impact of the extent of lymph node dissection on survival outcomes in clinically lymph node‐positive bladder cancer

How to Skin a Prostate: The Evolution of Robotic Prostatectomy

Oncolytic immunotherapy with nivolumab in muscle-invasive bladder cancer: a phase 1b trial.

A Phase II Study of Durvalumab for Bacillus Calmette-Guerin (BCG) Unresponsive Urothelial Carcinoma In Situ of the Bladder

Bacillus Calmette–Guérin (BCG) unresponsive non‐muscle‐invasive bladder cancer: are the subgroups equal?

Antegrade administration of mitomycin gel for upper tract urothelial carcinoma via percutaneous nephrostomy tube: a multi‐institutional retrospective cohort study

Effectiveness of perioperative chemotherapy and radical cystectomy in treating bladder cancer

Clinical indications for necessary and discretionary hospital readmissions after radical cystectomy

Clinical Utility of Cell-free and Circulating Tumor DNA in Kidney and Bladder Cancer: A Critical Review of Current Literature

Impact of upper tract urothelial carcinoma on response to BCG in patients with non‐muscle‐invasive bladder cancer

Time interval from transurethral resection of bladder tumour to bacille Calmette–Guérin induction does not impact therapeutic response

Re: Andrea Necchi, Laura Marandino, Daniele Raggi, et al. Is it Time to Consider Eliminating Surgery from the Treatment of Locally Advanced Bladder Cancer? Eur Urol 2021;79:713–6

Using oncolytic viruses to ignite the tumour immune microenvironment in bladder cancer

The obesity paradox: defining the impact of body mass index and diabetes mellitus for patients with non‐muscle‐invasive bladder cancer treated with bacillus Calmette–Guérin

Collaborators (13)

youngchul kim

Weranja Ranasinghe

Neema Navai

Jacob Taylor

Colin Dinney

Wei Shen Tan

Ahmet Murat Aydin

Justin Matulay

Andrea Mari

Gopal Narang

Paulo Rodriguez

Gustavo Borjas

Surena F. Matin

Make your next move.